tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Holding NKTR?
Track your performance easily

Nektar Therapeutics (NKTR) Ownership - Who Owns Nektar Therapeutics?

1,229 Followers

Nektar Therapeutics (NKTR) Ownership Overview

10.80%17.24%35.49%10.68%25.78%
10.80% Insiders
35.49% Other Institutional Investors
10.68% ETFs
25.78% Public Companies and
Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 63.41% of the company’s stock is owned by Institutional Investors, 10.80% is owned by Insiders, and 25.78% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 20, 2024
Howard Robin
President & Ceo,director
xxxxxxxxxxxxx
$16441
Nov 20, 2024
Jonathan Zalevsky
Chief R&d Officer
xxxxxxxxxxxxx
$7863
Aug 20, 2024
Howard Robin
President & Ceo,director
xxxxxxxxxxxxx
$19048
Aug 20, 2024
Jonathan Zalevsky
Chief R&d Officer
xxxxxxxxxxxxx
$8788

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$7686188

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
18,344,000Insider9.94%18,894,320
10,165,998Institution5.51%10,470,978
8,643,101Institution4.69%8,902,394
7,529,096Institution4.08%7,754,969
7,303,343Institution3.96%7,522,443
5,912,453Institution3.21%6,089,827
5,390,942Institution2.92%5,552,670
2,280,412Institution1.24%2,348,824
1,902,322Institution1.03%1,959,392
1,731,671Institution0.94%1,783,621

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,643,101Institution4.69%8,902,394
7,529,096Institution4.08%7,754,969
5,390,942Institution2.92%5,552,670
2,280,412Institution1.24%2,348,824
1,902,322Institution1.03%1,959,392
1,614,640Institution0.88%1,663,079
965,233Institution0.52%994,190
854,274Institution0.46%879,902
568,896Institution0.31%585,963
520,754Institution0.28%536,377

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,724,732Institution3.10%7,442,152
5,111,489Institution2.77%5,264,834
2,918,369Institution1.58%3,793,880
1,785,076Institution0.97%1,838,628
818,905Institution0.44%1,064,577
787,752Institution0.43%811,385
567,269Institution0.31%737,450
530,947Institution0.29%546,875
412,938Institution0.22%425,326
167,844Institution0.09%196,377

FAQ

Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 35.49% of the company's stock is held by institutional investors, 10.80% is held by insiders, and 25.78% is held by retail investors.
    What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 35.49% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
      What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 25.78% of Nektar Therapeutics (NKTR) stock is held by retail investors.
        Who owns the most shares of Nektar Therapeutics (NKTR)?
        Deep Track Capital, LP owns the most shares of Nektar Therapeutics (NKTR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis